A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone ...

The deal complements Jabil’s specialty in injectable drug delivery systems, like those used for popular GLP-1 diabetes drugs ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves ...

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

More Canadian employers are offering benefits that are not traditionally offered in most benefits programs, according to a recent report. Currently, 70 per cent of employers are offering fertility ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight loss medications known as GLP-1 receptor agonists, including the popular name brands Ozempic ...